Oxygen-releasing cell-carrying hydrogel for wound repair and preparation method thereof
By developing a releaseable oxygen-carrying cell hydrogel including microsphere structure and membrane layer, the problem of lack of a long-term oxygen release system in the prior art is solved, long-term oxygenation of damaged tissues is achieved, and stem cells are improved survival rate and wound healing effect.
Patent Information
- Application Number
- CN202410287353.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-13
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-03-13
AI Technical Summary
The lack of an oxygen release system in the prior art that can provide oxygen to damaged tissues for a long time leads to low survival rates of stem cells in the trauma site, limiting the efficacy and clinical application potential of stem cell therapy.
An oxygen-loaded cell hydrogel is used that includes a microsphere structure, a membrane layer coated on the outer surface of the microsphere structure, and mesenchymal stem cells seeded on the surface of the membrane layer. The microsphere structure consists of polyvinyl alcohol, sodium alginate and H2O2, and the membrane layer is composed of sodium alginate and H2O2 enzymes, which improve tissue oxygenation by slowly releasing oxygen.
This oxygen-releasable cell-loading hydrogel can release oxygen for a long time, improve the survival rate of stem cells, and promote wound healing, significantly improving the efficacy of stem cell therapy.
Smart Images

Figure BDA0004739534690000071 
Figure BDA0004739534690000072 
Figure BDA0004739534690000081
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of oxygen-releasing cell-laden hydrogels, and in particular to oxygen-releasing cell-laden hydrogels for wound repair and a preparation method thereof. Background Art
[0002] With the progress of stem cell research in recent years, stem cell-based therapy has become a method for treating trauma and improving patient prognosis. For example, the paper Yi-Zhou Huang, Min Gou, Lin-Cui Da, et al. Mesenchymal semcells for chronic wound healing: Current status of preclinical and clinical studies. Tissue Eng Part B Rev. 2020 Dec; 26(6): 555-570 states that local transplantation of mesenchymal stem cells can promote neovascularization, enhance wound cell recruitment and shrink wounds by paracrine secretion of EGF, VEGF and SDF-1; the paper Na Song, Martijn Scholtemeijer, Khalid Shah. Mesenchymal stem cell immunomodulation: Mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020 Sep; 41(9): 653-664 states that at the same time, mesenchymal stem cells can be activated by inflammatory cytokines, control the tissue regeneration process by releasing a series of factors that may promote progenitor cell differentiation and proliferation, and participate in immunoregulation and inhibition of inflammatory responses. Although mesenchymal stem cell therapy has been successful in a large number of basic studies (including in vitro and in vivo animal experiments) conducted at home and abroad, the retention rate of transplanted stem cells in peripheral tissues is still extremely low, which seriously limits the efficacy and clinical application potential of stem cell therapy; this point of view is mentioned in the paper Loubna Mazini, Luc Rochette, Brahim Admou, et al. Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing. Int J Mol Sci. 2020 Feb 14; 21(4): 1306.
[0003] It is worth noting that the wound site is an oxygen-deficient environment, and high levels of oxygen free radicals can easily cause oxidative stress, resulting in a very low survival rate of stem cells; this view is mentioned in the paper Seahyoung Lee, Eunhyun Choi, Min-Ji Cha, et al. Celladhesion and long-term survival of transplanted mesenchymal stem cells: A prerequisite for cell therapy. Oxid Med Cell Longev. 2015: 2015: 632902. In addition, chronic hypoxia caused by interrupted vascular supply and chronic inflammation will hinder the process of wound healing, so improving wound tissue oxygenation can effectively improve the survival of stem cells, improve wound healing and promote the epithelialization process. Although common hypoxic pretreatment and hyperbaric oxygen pretreatment can improve the survival rate of stem cells to a certain extent, the effect is relatively non-specific. In addition, some studies have also developed oxygen release systems for local implantation to improve cell survival by improving the hypoxic microenvironment at the site of cell implantation, thereby better utilizing the therapeutic effect of stem cells. However, these oxygenation systems typically release oxygen in less than two weeks, while blood vessel growth, granulation, and re-epithelialization require at least three weeks; this view is mentioned in the paper Tarun Agarwal, Sara Kazemi, Marco Costantini, et al. Oxygen releasing materials: Towards addressing the hypoxia-related issues in tissue engineering. Mater Sci Eng C Mater Biol Appl. 2021Mar: 122: 111896.
[0004] Therefore, it is urgent to develop oxygen release systems to provide oxygen to damaged tissues for a long time, thereby improving cell survival and better utilizing the therapeutic effects of stem cells. Summary of the invention
[0005] In view of the deficiencies in the prior art, the purpose of the present invention is to provide an oxygen-releasing cell-loaded hydrogel for wound repair and a preparation method thereof, so as to solve the technical problem in the prior art that there is no oxygen release system to provide oxygen to damaged tissues for a long time.
[0006] To achieve the above-mentioned purpose, the first aspect of the present invention adopts the following technical scheme: an oxygen-releasing cell-carrying hydrogel for wound repair, comprising a microsphere structure, a membrane layer coated on the outer surface of the microsphere structure, and mesenchymal stem cells seeded on the surface of the membrane layer; wherein the microsphere structure comprises polyvinyl alcohol, sodium alginate and H2O2; and the membrane layer comprises sodium alginate and H2O2 enzyme.
[0007] The second aspect of the present invention adopts the following technical scheme: a method for preparing an oxygen-releasing cell-carrying hydrogel for wound repair, including microsphere structure preparation, membrane layer formation and mesenchymal stem cell inoculation; wherein the microsphere structure preparation steps include: preparing polyvinyl alcohol sol; dripping a cross-linking agent on the surface of the polyvinyl alcohol sol; preparing a sodium alginate / H2O2 mixed solution, and covering the sodium alginate / H2O2 mixed solution on the surface of the polyvinyl alcohol sol after the cross-linking agent is added to form an initial microsphere structure; placing the initial microsphere structure at a certain temperature to react and then dripping a cross-linking agent on the surface of the initial microsphere structure to form a microsphere structure.
[0008] Furthermore, the film layer forming step includes: preparing a sodium alginate / H2O2 enzyme mixed solution, and covering the sodium alginate / H2O2 enzyme mixed solution on the surface of the microsphere structure; then placing the prepared structure at a certain temperature for reaction and then standing to defoam; placing the structure after standing in deionized water for immersion to obtain an oxygen-releasing hydrogel.
[0009] Furthermore, the mesenchymal stem cell inoculation step includes: sterilizing the oxygen-releasing hydrogel, then inoculating mesenchymal stem cells on the surface of the oxygen-releasing hydrogel, and then culturing for a period of time to obtain the oxygen-releasing cell-laden hydrogel.
[0010] Furthermore, the crosslinking agent is a glutaraldehyde / calcium chloride solution; preferably, the mass concentration of glutaraldehyde in the glutaraldehyde / calcium chloride solution is 2.5%-10%, and the mass concentration of calcium chloride is 0.5%-5%; further preferably, the mass concentration of glutaraldehyde is 5%, and the mass concentration of calcium chloride is 1%.
[0011] Furthermore, the certain temperature is 40°C-60°C, and the reaction time is 30-180 minutes; preferably, the certain temperature is 45°C, and the reaction time is 40 minutes.
[0012] Furthermore, the mass concentration of polyvinyl alcohol in the polyvinyl alcohol sol is 10%-30%; preferably, the mass concentration of polyvinyl alcohol is 15%.
[0013] Furthermore, the mass concentration of sodium alginate in the sodium alginate / H2O2 mixed solution is 1%-16%, and the mass concentration of H2O2 is 1%-10%;
[0014] Preferably, the mass concentration of sodium alginate is 8%, and the mass concentration of H2O2 is 5%.
[0015] Furthermore, the mass concentration of sodium alginate in the sodium alginate / H2O2 enzyme mixed solution is 2%-16%, and the mass concentration of H2O2 enzyme is 0.25-1 mg / mL; preferably, the mass concentration of sodium alginate is 8%, and the mass concentration of H2O2 enzyme is 0.5 mg / mL.
[0016] Furthermore, the seeding density of the mesenchymal stem cells is 2×10 3 -8×10 3 Pieces / cm 2 Preferably, the seeding density of mesenchymal stem cells is 5×10 3 Pieces / cm 2 .
[0017] Compared with the prior art, the present invention has the following beneficial effects:
[0018] The interior of the oxygen-releasing cell-carrying hydrogel is a porous interconnected structure, which allows metabolites and nutrients to be exchanged, can simulate the extracellular matrix environment, and is conducive to cell proliferation in vitro. Through repeated research and screening, the inventors found that polyvinyl alcohol has the characteristics of good biocompatibility and excellent mechanical properties. Stem cells are seeded on the surface of polyvinyl alcohol hydrogels to maintain long-term survival of cells in vitro. Furthermore, sodium alginate is used as a drug sustained-release system, and H2O2 is encapsulated in sodium alginate microspheres to be released slowly. Since H2O2 is not easy to decompose into oxygen at room temperature, the H2O2 enzyme and sodium alginate form a film layer wrapped on the surface of the microspheres, which can achieve the effect of slowly releasing oxygen. Furthermore, the released oxygen can be continuously provided to the cells and wound sites on the surface of the oxygen-releasing cell-carrying hydrogel, thereby improving cell survival rate and promoting wound healing. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 This is an appearance diagram of the oxygen-releasing hydrogel in Example 1 of the present invention;
[0020] Figure 2 The graphs are the mechanical properties, air permeability and swelling curves of oxygen-releasing cell-carrying hydrogel in Example 3 of the present invention;
[0021] Figure 3 This is an oxygen release curve of the oxygen-releasing cell-carrying hydrogel in Example 4 of the present invention;
[0022] Figure 4 This is a cell activity curve of the oxygen-releasing cell-carrying hydrogel in Example 5 of the present invention;
[0023] Figure 5 This is a diagram of rat wound repair using oxygen-releasing cell-laden hydrogel in Example 6 of the present invention. DETAILED DESCRIPTION
[0024] The present invention is further described in detail below through specific embodiments:
[0025] The first aspect of the present invention adopts the following technical scheme: an oxygen-releasing cell-carrying hydrogel for wound repair, comprising a microsphere structure, a film layer coated on the outer surface of the microsphere structure, and mesenchymal stem cells seeded on the surface of the film layer; wherein the microsphere structure comprises polyvinyl alcohol, sodium alginate, and H2O2; and the film layer comprises sodium alginate and H2O2 enzyme. The interior of the oxygen-releasing cell-carrying hydrogel is a porous interconnected structure, which allows metabolite and nutrient exchange, can simulate the extracellular matrix environment, and is conducive to cell proliferation in vitro. The inventors have found through repeated research and screening that polyvinyl alcohol has the characteristics of good biocompatibility and excellent mechanical properties. Stem cells are seeded on the surface of polyvinyl alcohol hydrogel to maintain long-term survival of cells in vitro. Furthermore, sodium alginate is used as a drug sustained-release system, and H2O2 is encapsulated in sodium alginate microspheres to be slowly released. Since H2O2 is not easy to decompose into oxygen at room temperature, the H2O2 enzyme and sodium alginate form a film layer and are wrapped on the surface of the microspheres, which can achieve the effect of slowly releasing oxygen. Furthermore, the released oxygen can be continuously provided to the cells on the surface of the oxygen-releasing cell-loaded hydrogel and the wound site, thereby increasing cell survival rate and promoting wound healing.
[0026] The second aspect of the present invention adopts the following technical scheme: a method for preparing oxygen-releasing cell-carrying hydrogel for wound repair, including microsphere structure preparation, membrane layer formation and mesenchymal stem cell inoculation; wherein the microsphere structure preparation step includes: preparing polyvinyl alcohol sol; dripping a crosslinking agent on the surface of the polyvinyl alcohol sol; preparing a sodium alginate / H2O2 mixed solution, and covering the sodium alginate / H2O2 mixed solution on the surface of the polyvinyl alcohol sol after dripping the crosslinking agent to form an initial microsphere structure; placing the initial microsphere structure at a certain temperature for reaction and then dripping a crosslinking agent on the surface of the initial microsphere structure to form a microsphere structure. Among them, the step of preparing polyvinyl alcohol sol specifically includes: dissolving polyvinyl alcohol in DMSO at a temperature of 65°C to prepare a polyvinyl alcohol solution, and then pouring the polyvinyl alcohol solution into a polytetrafluoroethylene mold; soaking the mold containing the polyvinyl alcohol solution in water for a period of time and then taking it out to form a polyvinyl alcohol sol. The polyvinyl alcohol-containing mold is placed in water and allowed to stand for 3 to 6 hours; wherein the standing time can be 3 hours, 3.5 hours, 4 hours, 4.5 hours, 5 hours, 5.5 hours or 6 hours; preferably, the standing time is 3 hours.
[0027] Furthermore, the film layer forming step includes: preparing a sodium alginate / H2O2 enzyme mixed solution, and covering the sodium alginate / H2O2 enzyme mixed solution on the surface of the microsphere structure; then placing the prepared structure at a certain temperature for reaction and then standing to defoam; placing the structure after standing in deionized water for immersion to obtain an oxygen-releasing hydrogel.
[0028] Furthermore, the mesenchymal stem cell inoculation step includes: sterilizing the oxygen-releasing hydrogel, then inoculating mesenchymal stem cells on the surface of the oxygen-releasing hydrogel, and then culturing for a period of time to obtain the oxygen-releasing cell-laden hydrogel.
[0029] Further, the cross-linking agent is a glutaraldehyde / calcium chloride solution; preferably, the mass concentration of glutaraldehyde in the glutaraldehyde / calcium chloride solution is 2.5%-10%, and the mass concentration of calcium chloride is 0.5%-5%; wherein the mass concentration of glutaraldehyde can be 2.5%, 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10%, and the mass concentration of calcium chloride can be 0.5%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5% or 5%; further preferably, the mass concentration of glutaraldehyde is 5%, and the mass concentration of calcium chloride is 1%.
[0030] Further, the certain temperature is 40°C-60°C, and the reaction time is 30-180 minutes; wherein, the certain temperature may be 40°C, 45°C, 50°C, 55°C or 60°C, and the reaction time may be 30 minutes, 40 minutes, 50 minutes, 60 minutes, 70 minutes, 80 minutes, 90 minutes, 100 minutes, 120 minutes, 140 minutes, 150 minutes, 160 minutes or 180 minutes; preferably, the certain temperature is 45°C, and the reaction time is 40 minutes.
[0031] Furthermore, the mass concentration of polyvinyl alcohol in the polyvinyl alcohol sol is 10%-30%; wherein the mass concentration of polyvinyl alcohol in the polyvinyl alcohol sol may be 10%, 15%, 20%, 25% or 30%; preferably, the mass concentration of polyvinyl alcohol is 15%.
[0032] Furthermore, the mass concentration of sodium alginate in the sodium alginate / H2O2 mixed solution is 1%-16%, and the mass concentration of H2O2 is 1%-10%; wherein the mass concentration of sodium alginate may be 1%, 2%, 3%, 4%, 5%, 6%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10%; preferably, the mass concentration of sodium alginate is 8%, and the mass concentration of H2O2 is 5%.
[0033] Furthermore, the mass concentration of sodium alginate in the sodium alginate / H2O2 enzyme mixed solution is 2%-16%, and the mass concentration of H2O2 enzyme is 0.25-1 mg / mL; wherein the mass concentration of sodium alginate may be 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15% or 16%, and the mass concentration of H2O2 enzyme may be 0.25 mg / mL, 0.5 mg / mL, 0.75 mg / mL or 1 mg / mL; preferably, the mass concentration of sodium alginate is 8%, and the mass concentration of H2O2 enzyme is 0.5 mg / mL.
[0034] Furthermore, the seeding density of the mesenchymal stem cells is 2×10 3 -8×10 3 Pieces / cm 2 ; Wherein, the seeding density of the mesenchymal stem cells can be 2×10 3 Pieces / cm 2 , 3×10 3 Pieces / cm 2 , 4×10 3 Pieces / cm 2 , 5×10 3 Pieces / cm 2 , 6×10 3 Pieces / cm 2 ,7×10 3 Pieces / cm 2 or 8×10 3 Pieces / cm 2 Preferably, the seeding density of mesenchymal stem cells is 5×10 3 Pieces / cm 2 .
[0035] Furthermore, the sterilization method is gamma irradiation sterilization.
[0036] Example 1 Preparation of oxygen-releasing hydrogel
[0037] 15 g of polyvinyl alcohol was dissolved in 100 mL of DMSO, and the mixture was stirred at 65° C. for 2 hours to completely dissolve the polyvinyl alcohol to prepare a polyvinyl alcohol solution with a mass concentration of 15%.
[0038] The polyvinyl alcohol solution was poured into a polytetrafluoroethylene mold, and then soaked in water for 3 hours and then taken out to form a polyvinyl alcohol sol.
[0039] 8 g of sodium alginate was dissolved in 80 mL of deionized water, and stirred at 65° C. for 3 hours to completely dissolve it, to prepare a sodium alginate solution with a mass concentration of 10%; and the solution was placed at 4° C. overnight to eliminate bubbles.
[0040] 1 mL of H2O2 with a mass concentration of 30% was mixed with 5 mL of sodium alginate solution, and then diluted to form a sodium alginate / H2O2 mixed solution; wherein the mass concentration of H2O2 in the sodium alginate / H2O2 mixed solution was 5%, and the mass concentration of sodium alginate was 8%.
[0041] 5 mg H2O2 enzyme was dissolved in 2 mL PBS solution and mixed with 8 mL sodium alginate solution to prepare a sodium alginate / H2O2 enzyme mixed solution; wherein the mass concentration of H2O2 enzyme in the sodium alginate / H2O2 enzyme mixed solution was 0.5 mg / mL, and the mass concentration of sodium alginate was 8%.
[0042] Dissolve 1 g of anhydrous calcium chloride in 100 mL of deionized water and stir well to prepare a 1% calcium chloride solution.
[0043] 5 mL of 50% glutaraldehyde was dissolved in 45 mL of calcium chloride solution, and the pH value was adjusted to 3.0 with dilute hydrochloric acid to prepare a glutaraldehyde / calcium chloride solution.
[0044] Glutaraldehyde / calcium chloride solution was added dropwise on the surface of the polyvinyl alcohol sol.
[0045] The sodium alginate / H2O2 mixed solution was dripped onto the surface of the polyvinyl alcohol sol using the dripping method to form sodium alginate / H2O2 microspheres, which were then placed in an oven at 45°C for reaction for 30 minutes and then taken out.
[0046] Then, glutaraldehyde / calcium chloride solution was dripped onto the surface of the microspheres, and then sodium alginate / H2O2 enzyme mixed solution was dripped onto the surface of the microspheres using the drip method, thereby forming a sodium alginate / H2O2 enzyme film on the surface of the microspheres; the microspheres were placed in an oven at 45°C for reaction for 30 minutes, then taken out and placed in a 4°C environment for overnight.
[0047] The mold was immersed in deionized water for 48 hours, and the deionized water was replaced every 6 hours. After demolding, the oxygen-releasing hydrogel was obtained; Figure 1 shown.
[0048] Example 2 Preparation of oxygen-releasing cell-carrying hydrogel
[0049] Extraction of umbilical cord mesenchymal stem cells: The umbilical cord was removed aseptically, and the outer membrane and arteries and veins were removed and cut into 1 mm pieces. 3 The tissue blocks were placed in complete culture medium (purchased from Pronocell) and cultured in a cell culture incubator at 37°C and 5% CO2. After 3 days, adherent cells could be seen crawling out from the edge of the tissue and covering the bottom of the flask after about 7 days. After trypsin digestion, 3 × 10 4 Pieces / cm 2 The cells were subcultured at a density of 1.54 μg / mL and the third generation cells were used for subsequent experiments.
[0050] The oxygen-releasing hydrogel prepared in Example 1 was sterilized by gamma irradiation, and then umbilical cord mesenchymal stem cells were cultured at a rate of 5×10 3 Pieces / cm 2 The cells were inoculated at a density of 100 μg / cm2 on the surface of the oxygen-releasing hydrogel, and then placed in a 37°C, 5% CO2 incubator for 2 hours. Complete culture medium was then added until the hydrogel was covered to obtain the oxygen-releasing cell-laden hydrogel.
[0051] Example 3 Testing of mechanical properties, water vapor permeability and swelling rate of oxygen-releasing hydrogel
[0052] Mechanical properties test: Referring to YY / T 1435-2016 Guidelines for Characterization of Hydrogels for Tissue Engineering Medical Devices, hydrogels with a PVA content of 10%, hydrogels with a PVA content of 15%, and hydrogels with a PVA content of 20% were cut into 40 mm × 10 mm strips, and tested using a universal tensile testing machine at a tensile speed of 50 mm / min at room temperature. The tensile strength (σ) and elongation at break (ε) were calculated using the following formulas:
[0053] (1)σ=F / (b×h)
[0054] Wherein σ is the tensile strength, in MPa; F is the maximum tensile force, in N; b is the width of the spline, in mm; h is the thickness of the spline, in mm.
[0055] (2)ε=(L-L0) / L0×100%
[0056] Where ε is the elongation at break; L is the length of the spline after stretching, in mm; L0 is the length of the sample itself, in mm.
[0057] Water vapor transmission rate test: According to the method of YYT0471.2-2004 Test Method for Contact Wound Dressing Part 2 - Water Vapor Transmission Rate of Breathable Film Dressing, oxygen-releasing hydrogels with different PVA concentrations are fixed on the moisture permeable cup, such as Figure 2 As shown. The initial hydrogel, the permeable cup and the liquid in the cup were weighed, placed in a 37°C oven for 4 hours and weighed again. The water vapor permeability of the hydrogel was calculated according to the following formula:
[0058] Water vapor transmission rate (MVTR) = (W1-W2) × 1000 × 24 / T
[0059] The water vapor transmission rate (MVTR) is expressed in grams per square meter per 24 hours (g·m -2 ·24h -1); W1 is the mass of the container, sample and liquid, in grams (g); W2 is the mass of the container, sample and liquid after the test period, in grams (g); T is the test period, in hours (h).
[0060] Hydrogel swelling test: The hydrogel was completely dried in an oven, weighed, and then immersed in a 37°C PBS solution to evaluate the swelling of the sample. Each sample was weighed again after removing excess liquid every 2 hours. The weight of each sample was recorded until the weight change became negligible. The swelling rate was calculated by the following equation.
[0061] Swelling rate (%) = (W t -W0) / W0×100%
[0062] Where W t is the sample weight after immersion in PBS and W0 is the initial dry sample weight.
[0063] The results of tensile strength, elongation at break, water vapor permeability and swelling rate of hydrogel are as follows: Figure 2 As shown in Table 1 and Table 2.
[0064] Table 1 Statistics of tensile strength and elongation at break of hydrogels with different PVA concentrations
[0065]
[0066] Table 2 Statistics of water vapor permeability of hydrogels with different PVA concentrations
[0067]
[0068]
[0069] The results show that the average tensile strength of the hydrogel with a PVA content of 10% by mass is 0.028Mpa, and the average elongation at break is 168.238%. The average tensile strength of the hydrogel with a PVA content of 15% by mass is 0.037Mpa, and the average elongation at break is 183.986%. The average tensile strength of the hydrogel with a PVA content of 20% by mass is 0.046Mpa, and the average elongation at break is 200.680%. With the increase of PVA concentration, the mechanical properties of the hydrogel are improved. The average water vapor permeability of the hydrogel with a PVA content of 10% by mass is 4596g·m -2 ·24h -1 The average water vapor rate of the hydrogel with a mass concentration of 15% PVA is 2616 g·m -2 ·24h -1 The average water vapor rate of the hydrogel with a mass concentration of 20% PVA is 1992 g·m -2·24h -1 As the PVA concentration increases, the water vapor permeability of the hydrogel decreases, but it is still 500 g·m higher than that of normal skin. -2 ·24h -1 The permeability can effectively reduce the accumulation of exudate. As an ideal wound dressing material, the ability of hydrogel to absorb and retain liquid is an important aspect to evaluate its effect. The swelling rate of hydrogel is an important indicator to evaluate the ability of gel to absorb liquid. After 16 hours, the swelling rate of hydrogel gradually slowed down, and the swelling equilibrium was basically reached after 20 hours. The swelling rate of hydrogel decreases with the increase of PVA concentration. The swelling rate of hydrogel with a mass concentration of 10%-20% PVA content is between 200% and 350%, and has good water absorption.
[0070] In this embodiment: the hydrogel with a PVA content of 15% by mass is the oxygen-releasing hydrogel prepared in Example 1; the hydrogel with a PVA content of 10% by mass is different from the oxygen-releasing hydrogel prepared in Example 1 only in that: 10g of polyvinyl alcohol is dissolved in 100mL of DMSO, and stirred at 65°C for 2 hours to completely dissolve it to prepare a polyvinyl alcohol solution with a mass concentration of 10%; the hydrogel with a PVA content of 20% by mass is different from the oxygen-releasing hydrogel prepared in Example 1 only in that: 20g of polyvinyl alcohol is dissolved in 100mL of DMSO, and stirred at 65°C for 2 hours to completely dissolve it to prepare a polyvinyl alcohol solution with a mass concentration of 10%.
[0071] Example 4 Oxygen Release Detection of Oxygen-Releasable Hydrogel
[0072] Hydrogels with H2O2 contents of 1.25%, 2.5% and 5% were prepared respectively. In this embodiment, the hydrogel with H2O2 content of 5% was the oxygen-releasing hydrogel prepared in Example 1. The difference between the preparation of the hydrogel with H2O2 content of 1.25% and Example 1 was that 0.25 mL of H2O2 with a mass concentration of 30% was mixed with 5 mL of sodium alginate solution, and then diluted to form a sodium alginate / H2O2 mixed solution; wherein, the sodium alginate / H2O 2 The mass concentration of H2O2 in the mixed solution is 1.25%, and the mass concentration of sodium alginate is 8%; the preparation of the hydrogel with a H2O2 content of 2.5% is different from that of Example 1 only in that: 0.5 mL of H2O2 with a mass concentration of 30% is mixed with 5 mL of sodium alginate solution, and then diluted to form a sodium alginate / H2O2 mixed solution; wherein the mass concentration of H2O2 in the sodium alginate / H2O2 mixed solution is 1.25%, and the mass concentration of sodium alginate is 8%.
[0073] The prepared hydrogels with H2O2 contents of 1.25%, 2.5% and 5% were named 1.25% H2O2 group, 2.5% H2O2 group and 5% H2O2 group, respectively.
[0074] The 1.25% H2O2 group, 2.5% H2O2 group and 5% H2O2 group were operated as follows:
[0075] The hydrogel was placed in a container filled with PBS solution, and the container was placed in an anoxic chamber. At the beginning of the test, nitrogen was injected into the PBS solution for 3 minutes to deoxygenate it. The solution was incubated at 37°C for 24 hours, and a dissolved oxygen meter was used to measure the oxygen released on the same day. The dissolved oxygen concentration in PBS was measured at different time points. After each measurement, the PBS solution needed to be deoxygenated again. An oxygen-releasing hydrogel without H2O2 was also provided as a blank control (the difference between the blank control and the 1.25% H2O2 group, the 2.5% H2O2 group, or the 5% H2O2 group was only the H2O2 content). The oxygen release curve of the hydrogel is shown in the figure below. Figure 3 shown.
[0076] The results show that the 1.25% H2O2 group, 2.5% H2O2 group and 5% H2O2 group all detected higher dissolved oxygen concentrations than the control group on the first day, and the oxygen solubility released by the 5% H2O2 group increased significantly. The oxygen release of the three groups of hydrogels, 1.25% H2O2 group, 2.5% H2O2 group and 5% H2O2, reached a peak on the 7th day, and then the dissolved oxygen concentration gradually decreased, and was still slightly higher than the control group on the 20th day. The results show that the hydrogel has the function of long-term oxygen release.
[0077] Example 5 Cytotoxicity Detection of Oxygen-Releasable Cell-Loaded Hydrogel
[0078] Oxygen-releasing cell-laden hydrogels with H2O2 mass concentrations of 1.25% and 2.5% were also prepared in the manner of Example 2. The difference between the oxygen-releasing cell-laden hydrogels and Example 2 is that different amounts of H2O2 were added to the sodium alginate / H2O2 mixed solution in the oxygen-releasing cell-laden hydrogels.
[0079] The cytotoxicity of oxygen-releasing cell-carrying hydrogels with H2O2 mass concentrations of 1.25%, 2.5% and 5% was tested using a resazurin kit on days 1, 3 and 7. The absorbance (OD value) was measured at 570 nm using an ELISA reader, and an oxygen-releasing cell-carrying hydrogel that only differed in that it did not contain H2O2 was also designed as a control. The calculation formula for the relative proliferation rate (RGR, %) is as follows:
[0080] RGR (%) = (OD 实验组 -OD 空白 ) / (OD 对照组 -OD 空白 )×100%
[0081] The relative cell proliferation rates at different time periods are Figure 4 As shown. The results show that the oxygen-releasing cell-carrying hydrogels containing H2O2 at a mass concentration of 1.25% and 5% have no obvious toxicity to cells, and the oxygen-releasing cell-carrying hydrogels containing H2O2 at a mass concentration of 2.5% significantly increase the relative proliferation rate of cells after 3 days of culture. The results show that an appropriate concentration of dissolved oxygen is beneficial to cell proliferation.
[0082] Example 6 Cytotoxicity Detection of Oxygen-Releasable Cell-Loaded Hydrogel
[0083] Construction of a rat full-thickness skin injury model: SD rats were anesthetized with 7% chloral hydrate (dose of 5 mL / kg), fixed to the operating board in a prone position with medical tape, the back skin was prepared, hair was removed, and disinfected. A square incision with a side length of 2 cm was made on the upper middle back. The full-thickness skin at the marked site was cut to the fascia layer. After modeling, the rats were randomly divided into 4 groups, 10 rats in each group, and kept in separate cages. The four groups of rats were blank group, cell injection group, 2.5% H2O2 non-cell-loaded dressing group, and 2.5% H2O2 cell-loaded dressing group. The blank group was bandaged with medical gauze, and the cell injection group was injected with a total of 5×10 6 The wounds were bandaged with medical gauze. The 2.5% H2O2 non-cell-loaded dressing group was attached with 2.5% H2O2 hydrogel on the wounds, and the 2.5% H2O2 cell-loaded dressing group was attached with 2.5% H2O2 hydrogel on the wounds (5×10 6 umbilical cord mesenchymal stem cells).
[0084] The above-mentioned "2.5% H2O2 non-cell-loaded dressing group adhered a 2.5% H2O2 hydrogel to the wound" means that the 2.5% H2O2 non-cell-loaded dressing group adhered an oxygen-releasing hydrogel to the wound. The oxygen-releasing hydrogel is different from the oxygen-releasing hydrogel prepared in Example 1 in that the amount of H2O2 added to the prepared sodium alginate / H2O2 mixed solution is different. The mass concentration of H2O2 in the sodium alginate / H2O2 mixed solution in Example 1 is 5%, while the mass concentration of H2O2 here is 2.5%. The above-mentioned "2.5% H2O2 cell-loaded dressing group adhered a 2.5% H2O2 hydrogel to the wound (5×10 6umbilical cord mesenchymal stem cells)" that is, in the 2.5% H2O2 cell-loaded dressing group, oxygen-releasing cell-loaded hydrogel is attached to the wound. The oxygen-releasing cell-loaded hydrogel is different from the oxygen-releasing cell-loaded hydrogel prepared in Example 2 in that the amount of H2O2 added to the oxygen-releasing hydrogel in the preparation of the sodium alginate / H2O2 mixed solution is different. The mass concentration of H2O2 in the sodium alginate / H2O2 mixed solution in Example 1 is 5%, and the mass concentration of H2O2 here is 2.5%. At 1 day, 3 days, 7 days, 11 days, 15 days and 20 days after the injury, the degree of scab on the wound was observed, photographed and recorded, and the wound area was measured using Image J image analysis software. The wound healing rate (WHR) of each group at different time points was calculated according to the following formula:
[0085] WHR(%)=(S-S′) / S×100%
[0086] Where S is the area of skin removed during injury, and S′ is the wound area at different time points.
[0087] TNF is produced by monocytes and macrophages. As an important inflammatory mediator, it is particularly valued. When secreted in appropriate amounts, it can play an immunomodulatory and anti-infective role, but when secreted excessively, it can cause septic shock and multiple organ failure. TNF-α can stimulate the release of other cytokines such as IL-6 and IL-8, expanding their biological effects. IL-6 is produced by T cells, monocytes, etc., and can induce B cells to produce immunoglobulins and acute phase proteins. It can be used as an important indicator to reflect the severity of inflammation and disease. IL-10 is an acidic protein mainly produced by TH2 cells. IL-10 can inhibit macrophage antigen presentation, inhibit macrophage antigen activation and secondary cellular immune response, and has a wide range of inhibitory effects on the synthesis and function of monocytes and macrophages and cytokines. TNF-α, IL-6, and IL-10 are used as evaluation indicators of inflammatory response. At 3, 7, 11, 15 and 20 days after injury, the rats in each group were killed, and the skin tissues at the wounds were taken to extract the proteins in the tissue homogenate. ELISA kits were used to detect the expression levels of TNF-α, IL-6 and IL-10 in the tissues.
[0088] Table 3 Statistics of wound healing rates of different dressing groups at different time points
[0089]
[0090] Compared with the blank group: *p<0.05, **p<0.01.
[0091] From Table 3 and Figure 5As far as we know, the oxygen-releasing cell-loaded hydrogel showed good wound healing function on the 7th day, and the cell injection group took longer to take effect. In addition, the oxygen-releasing cell-loaded hydrogel showed good inflammation inhibition function, which could significantly reduce the expression of inflammatory factors TNF-α and IL-6, while increasing the expression of anti-inflammatory factor IL-10. The results showed that the oxygen-releasing cell-loaded hydrogel can enhance the repair ability of mesenchymal stem cells in vivo.
[0092] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the purpose and scope of the technical solution of the present invention, which should be included in the scope of the claims of the present invention.
Claims
1. A method for preparing oxygen-releasing cell-carrying hydrogel for wound repair, characterized in that: Including microsphere structure preparation, membrane formation and mesenchymal stem cell seeding; Wherein, the microsphere structure preparation step comprises: preparing polyvinyl alcohol sol; Add a cross-linking agent dropwise onto the surface of the polyvinyl alcohol sol; A sodium alginate / H2O2 mixed solution is prepared, and the sodium alginate / H2O2 mixed solution is covered on the surface of the polyvinyl alcohol sol after the cross-linking agent is added to form an initial microsphere structure; The initial microsphere structure is placed under a certain temperature for reaction and then a cross-linking agent is added dropwise on the surface of the initial microsphere structure to form a microsphere structure; The film layer forming step comprises: preparing a sodium alginate / H2O2 enzyme mixed solution, and covering the surface of the microsphere structure with the sodium alginate / H2O2 enzyme mixed solution; The prepared structure is then placed at a certain temperature for reaction and then allowed to stand for defoaming; The structure after standing still is immersed in deionized water to obtain an oxygen-releasing hydrogel; The mesenchymal stem cell inoculation step comprises: The oxygen-releasing hydrogel is sterilized, and then mesenchymal stem cells are inoculated on the surface of the oxygen-releasing hydrogel, and then cultured for a period of time to obtain the oxygen-releasing cell-carrying hydrogel; The certain temperature is 40° C.-60° C., and the reaction time is 30-180 minutes.
2. The method for preparing the oxygen-releasing cell-laden hydrogel for wound repair according to claim 1, characterized in that: The cross-linking agent is glutaraldehyde / calcium chloride solution.
3. The method for preparing the oxygen-releasing cell-laden hydrogel for wound repair according to claim 2, characterized in that: The mass concentration of glutaraldehyde in the glutaraldehyde / calcium chloride solution is 2.5%-10%, and the mass concentration of calcium chloride is 0.5%-5%.
4. The method for preparing the oxygen-releasing cell-laden hydrogel for wound repair according to claim 3, characterized in that: The mass concentration of the glutaraldehyde is 5%, and the mass concentration of calcium chloride is 1%.
5. The method for preparing the oxygen-releasing cell-laden hydrogel for wound repair according to claim 1, characterized in that: The certain temperature is 45° C., and the reaction time is 40 minutes.
6. The method for preparing oxygen-releasing cell-laden hydrogel for wound repair according to claim 1, characterized in that: The mass concentration of polyvinyl alcohol in the polyvinyl alcohol sol is 10%-30%.
7. The method for preparing oxygen-releasing cell-laden hydrogel for wound repair according to claim 6, characterized in that: The mass concentration of the polyvinyl alcohol is 15%.
8. The method for preparing oxygen-releasing cell-laden hydrogel for wound repair according to claim 1, characterized in that: The mass concentration of sodium alginate in the sodium alginate / H2O2 mixed solution is 1%-16%, and the mass concentration of H2O2 is 1%-10%.
9. The method for preparing oxygen-releasing cell-laden hydrogel for wound repair according to claim 8, characterized in that: The mass concentration of the sodium alginate is 8%, and the mass concentration of H2O2 is 5%.
10. The method for preparing oxygen-releasing cell-laden hydrogel for wound repair according to claim 1, characterized in that: The mass concentration of sodium alginate in the sodium alginate / H2O2 enzyme mixed solution is 2%-16%, and the mass concentration of H2O2 enzyme is 0.25-1 mg / mL.
11. The method for preparing oxygen-releasing cell-laden hydrogel for wound repair according to claim 10, characterized in that: The mass concentration of the sodium alginate is 8%, and the mass concentration of the H2O2 enzyme is 0.5 mg / mL.
12. The method for preparing oxygen-releasing cell-laden hydrogel for wound repair according to claim 1, characterized in that: The seeding density of the mesenchymal stem cells was 2×10 3 -8×10 3 Pieces / cm 2 .
13. The method for preparing oxygen-releasing cell-laden hydrogel for wound repair according to claim 12, characterized in that: The seeding density of the mesenchymal stem cells was 5×10 3 Pieces / cm 2 .
Citation Information
Patent Citations
Anti-adhesion hydrogel, preparation method thereof, and application of anti-adhesion hydrogel in preparation of epidermal wound dressing
CN113248736A
Oxygen sustained-release microsphere, preparation method and use method thereof, and application of oxygen sustained-release microsphere in treatment of diabetic foot and tumor diseases
CN115212183A
Composition comprising oxygen-releasing microcapsules containing hydrogen peroxide for enhancing cell protection and viability at room temperature
US20140220684A1
